Geoffrey M. Parker joined our board of directors in June 2010. Mr. Parker is currently the Senior Vice President and Chief Financial Officer for Anacor Pharmaceuticals, a biopharmaceutical company developing novel small-molecule therapeutics, were he has served in a consulting capacity since December of 2009. From July 2009 to July 2010, Mr. Parker acted as an advisor in his role as the Chief Business Officer of InteKrin Therapeutics, a privately held biopharmaceutical company in Los Altos, California. From 1997 to April 2009, Mr. Parker was a vice president, then managing director and finally partner at the global investment banking and securities firm Goldman Sachs Group, Inc., leading their West Coast Healthcare Investment Banking practice during this time. Mr. Parker also served in various capacities with Goldman Sachs Group, Inc. from 1990 to 1995 and 1986 to 1988. From 1995 to 1997, Mr. Parker was vice president at Feibusch & Co., a venture capital firm in Larkspur, California. Mr. Parker is currently a member of the board of directors for ChemoCentryx, Inc., a clinical stage privately held biopharmaceutical company. Mr. Parker received an A.B. from Dartmouth College in Engineering Sciences and Economics and an M.B.A. from Stanford University.